MedTrace Logo

Investigation of the Effect of Pedal Technique Training Protocol on Functional Threshold Power Test and Lower Extremity Isokinetic Power

NCT07160140 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2025-09-08

No results posted yet for this study

Summary

Abstract Purpose: The objective of this study is to assess the influence of pedal technique development training regimen on functional threshold power, lower extremity knee isokinetic power, and right-left knee power ratio differences.

Methods: Twenty-three male athletes with an average age of 15-17 years in the youth division of road cycling voluntarily participated in the study. Within the scope of the study, height, body weight, body fat ratio measurements, functional threshold power, pedal analysis tests, and lower extremity knee power measurements were performed as pre-test and post-test. Athletes participated in an 8-week, two-day-per-week pedal technique development training program. Statistical analyses were planned to be carried out on the data gathered from these measurements, calculations, and tests.

Conditions

  • Isokinetic Test
  • Cyclists
  • Performance Enhancement

Interventions

OTHER

Participants will receive an 8-week pedal technique training protocol in addition to their regular cycling training.

Pedal Technique Training Protocol This training is designed as a technical training to observe pedaling data, analyze right and left leg power ratios, and determine how they change when pedaling at various intensities and cadences

Sponsors & Collaborators

  • Istanbul Topkapi University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
17 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-20
Primary Completion
2022-07-20
Completion
2022-10-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07160140 on ClinicalTrials.gov